OrbiMed’s Arqule Inc ARQL Stock Holding History

OrbiMed’s Portfolio ARQL Stock Details ARQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,000,000	Closed	-$99.8M	–	171
2019 Q4	$99.8M	Buy	5,000,000 +1,298,727	+35%	+$15.1M	1.42%	23
2019 Q3	$26.5M	Buy	3,701,273 +2,701,273	+270%	+$25.4M	0.5%	50
2019 Q2	$11M	Buy	+1,000,000	New	+$6.96M	0.17%	90
2015 Q2	–	Sell	-4,896,108	Closed	-$11M	–	156
2015 Q1	$11M	Sell	4,896,108 -805,892	-14%	-$1.28M	0.09%	100
2014 Q4	$6.96M	Hold	5,702,000	–	–	0.07%	105
2014 Q3	$6.39M	Hold	5,702,000	–	–	0.07%	109
2014 Q2	$8.84M	Hold	5,702,000	–	–	0.1%	92
2014 Q1	$11.7M	Hold	5,702,000	–	–	0.14%	84
2013 Q4	$12.3M	Buy	5,702,000 +1,336,000	+31%	+$3.01M	0.18%	77
2013 Q3	$10.2M	Buy	4,366,000 +1,562,000	+56%	+$3.92M	0.18%	77
2013 Q2	$6.5M	Buy	+2,804,000	New	+$7.56M	0.14%	93

Other funds holding ARQL

DAM

Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return

OrbiMed's ARQL Position: Q1 2020 in Review

OrbiMed sold out of Arqule Inc (ARQL) in Q1 2020, closing a stake of 5,000,000 shares — an estimated $99.8M sold.

OrbiMed first reported a position in ARQL in Q2 2013 and held it in 11 quarters. The position peaked at $99.8M in Q4 2019. 1 fund tracked by Wall St. Rank holds ARQL as of Q1 2020.

OrbiMed reported no remaining Arqule Inc position as of Q1 2020 after selling out during the quarter.
OrbiMed sold 5,000,000 Arqule Inc shares in Q1 2020, an estimated $99.8M.
OrbiMed first reported a position in Arqule Inc in Q2 2013 and held it in 11 quarters.
OrbiMed's Arqule Inc position peaked at $99.8M in Q4 2019.
1 fund tracked by Wall St. Rank held Arqule Inc as of Q1 2020.

Based on OrbiMed's 13F filing for Q1 2020, filed 15 May 2020.